What's Going On With NRX Pharmaceuticals Stock Thursday?
What's Going On With NRX Pharmaceuticals Stock Thursday?
The network is set to be called the HOPE network of which Dr. NRX Pharmaceuticals (NASDAQ:NRXP) shares are trading higher on Thursday after the company's Hope Therapeutics subsidiary announced the planed acquisition of Kadima Neuropsychiatry Institute.
NRX製藥（納斯達克：NRXP）股票在週四上漲，因爲公司的Hope Therapeutics子公司宣佈計劃收購Kadima神經精神科研究所。
The acquisition is part of a broader plan by NRX and Hope to establish a network of clinics for treating depression and PTSD, with Kadima set to become the flagship location.
此次收購是NRX和Hope建立一系列治療抑鬱症和創傷後應激障礙（PTSD）診所更廣泛計劃的一部分，Kadima將在其中成爲旗艦地點。
NRX highlights Kadima as a leading interventional psychiatry clinic, known for introducing ketamine therapy for central nervous system disorders at scale. The clinic also offers treatments such as Spravato, transcranial magnetic stimulation and medication management for conditions like suicidal depression, PTSD and anxiety.
NRX強調Kadima作爲一家領先的干預精神病診所，以在大規模引入氯胺酮療法治療中樞神經系統疾病而聞名。該診所還提供治療，如Spravato、經顱磁刺激和藥物管理，針對自殺性抑鬱症、PTSD和焦慮等疾病。
The network is set to be called the HOPE network of which Dr. David Feifel will serve as the Chief Medical Innovation Officer.
該網絡將被稱爲HOPE網絡，David Feifel博士將擔任首席醫療創新官。
"I am thrilled to join the leadership of HOPE at this exciting juncture," said Feifel.
Feifel表示：「我很激動能在這個激動人心的時刻加入HOPE的領導層。」
"In a world where nearly 60 million Americans suffer from a mental illness in any given year, our dream has been to expand the successes and learnings of Kadima to an international stage, where we can continue to innovate and refine treatments that will create a world in which suicidal depression and PTSD are 100% treatable conditions, from which patients and their families should expect to return to empowered and productive lives."
Feifel說：「在美國近6000萬成年人在任何一年中遭受心理疾病的情況下，我們的夢想是將Kadima的成功和經驗擴展到國際舞臺，讓我們能夠繼續創新和完善治療，創造一個自殺性抑鬱症和PTSD可以100%治癒的世界，讓患者及其家庭能夠期待重新過上充實和富有成效的生活。」
Related Link: Fair Isaac Unusual Options Activity
相關鏈接：Fair Isaac 期權異動
NRXP Price Action: At the time of publication, NRX stock is trading 42.3% higher at $3.13, according to data from Benzinga Pro.
NRXP價格動態：根據Benzinga Pro的數據，在發佈時，NRX股票上漲了42.3%，交易價格爲3.13美元。
Image: Akava Photo from Pixabay
圖片：來自Pixabay的Akava Photo
譯文內容由第三人軟體翻譯。
